Drug profile · INN
glucagon hydrochloride
GLUCAGON
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
glucagon hydrochloride (GLUCAGON) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular, intravenous, subcutaneous. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12421317
Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonist antibodies
granted -
US 12269889
Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels
granted -
US 12208071
Glucagon receptor antagonists
granted -
US 12139546
Methods of treating urea cycle disorders by interfering with glucagon receptor signaling
granted -
US 12090193
Glucagon-like peptide 1 receptor agonists and uses thereof
granted -
US 11951176
Stabilization of glucagon by trehalose glycopolymer nanogels
granted -
US 11884736
Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)
granted -
US 11779633
Glucagon-like peptide 1 receptor agonists and uses thereof
granted
Frequently asked questions
What is glucagon hydrochloride?
glucagon hydrochloride (GLUCAGON) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular, intravenous, subcutaneous. Current US regulatory status: approved.
What is the brand name for glucagon hydrochloride?
GLUCAGON is a marketed brand name for glucagon hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of glucagon hydrochloride?
glucagon hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.